Anthera Pharmaceuticals Inc. buy Maxi_Scalibusa
Start price
23.02.18
/
50%
€2.16
Target price
15.03.18
€3.61
Performance (%)
-81.38%
End price
15.03.18
€0.40
Summary
This prediction ended on 15.03.18 with a price of €0.40. The BUY prediction by Maxi_Scalibusa for Anthera Pharmaceuticals Inc. performed very badly with a performance of -81.38%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Anthera Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by Maxi_Scalibusa for this prediction
In the thread Anthera Pharmaceuticals Inc. diskutieren
Maxi-Scalibusa stimmt der Buy-Einschätzung von stratec zu
Maxi-Scalibusa stimmt am 22.02.2018 der Buy-Einschätzung von stratec mit dem Kursziel 4$ zu.
Überschrift: Anthera Pharmaceuticals initiated with Buy rating and $10 (492% upside) price target at ROTH Capital.
(Vom Mitglied beendet)